Lion Chemtech Balance Sheet Health
Financial Health criteria checks 5/6
Lion Chemtech has a total shareholder equity of ₩127.8B and total debt of ₩17.0B, which brings its debt-to-equity ratio to 13.3%. Its total assets and total liabilities are ₩154.4B and ₩26.7B respectively. Lion Chemtech's EBIT is ₩7.7B making its interest coverage ratio -5.2. It has cash and short-term investments of ₩35.5B.
Key information
13.3%
Debt to equity ratio
₩17.00b
Debt
| Interest coverage ratio | -5.2x |
| Cash | ₩35.49b |
| Equity | ₩127.78b |
| Total liabilities | ₩26.66b |
| Total assets | ₩154.43b |
Recent financial health updates
Recent updates
We Think That There Are More Issues For Lion Chemtech (KOSDAQ:171120) Than Just Sluggish Earnings
Sep 08
Lion Chemtech (KOSDAQ:171120) Seems To Use Debt Rather Sparingly
Apr 05Can You Imagine How Lion Chemtech's (KOSDAQ:171120) Shareholders Feel About The 30% Share Price Increase?
Mar 12What Is The Ownership Structure Like For Lion Chemtech Co., Ltd. (KOSDAQ:171120)?
Feb 19Should You Be Adding Lion Chemtech (KOSDAQ:171120) To Your Watchlist Today?
Feb 01
Lion Chemtech Co., Ltd.'s (KOSDAQ:171120) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Jan 12Should You Rely On Lion Chemtech's (KOSDAQ:171120) Earnings Growth?
Dec 22Would Shareholders Who Purchased Lion Chemtech's (KOSDAQ:171120) Stock Five Years Be Happy With The Share price Today?
Dec 03Financial Position Analysis
Short Term Liabilities: A171120's short term assets (₩77.0B) exceed its short term liabilities (₩26.6B).
Long Term Liabilities: A171120's short term assets (₩77.0B) exceed its long term liabilities (₩77.7M).
Debt to Equity History and Analysis
Debt Level: A171120 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if A171120's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: A171120's debt is well covered by operating cash flow (67.4%).
Interest Coverage: A171120 earns more interest than it pays, so coverage of interest payments is not a concern.